Serotonin, neural markers and memory

Frontiers in Pharmacology

Volumn 6, Issue JUN, 2015, Pages

  Meneses, Alfredo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Drugs; Memory; Neural markers

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 (BROMO 3,6 DIMETHOXYBENZOCYCLOBUTEN 1 YL)METHYLAMINE HYDROBROMIDE; 4 AMINOBUTYRIC ACID; BREXPIPRAZOLE; DOPAMINE TRANSPORTER; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE RECEPTOR 5; IDALOPIRDINE; RS 39604; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2A AGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 3A RECEPTOR; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; SEROTONIN 5 RECEPTOR; SEROTONIN 5A RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN TRANSPORTER; TANDOSPIRONE; UNCLASSIFIED DRUG;

AGGRESSION; AGING; AMNESIA; ARTICLE; AUTISM; BINDING SITE; CONDITIONING; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; LEARNING; MEMORY; MEMORY DISORDER; NERVOUS SYSTEM INFLAMMATION; NEUROTRANSMISSION; NONHUMAN; PAVLOVIAN AUTOSHAPING; PROTEIN EXPRESSION; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84936945671     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00143     Document Type: Article

References (214)

1. Abela AR, Dougherty SD, Fagen ED, Hill CJR and Chudasama Y. Inhibitory Control Deficits in Rats with Ventral Hippocampal Lesions. Cerebral Co0rtex June 2013;23:1396-1409.
2. Alabdali A, Al-Ayadhi L, El-Ansary A. Association of social and cognitive impairment and biomarkers in autism spectrum disorders. J Neuroinflammation. 2014 Jan 8;11:4.
3. 2C receptors. Pharmacol Ther. 2009 Feb;121(2):160-73.
4. Atnip GW. Stimulus-and response-reinforcer contingencies in autoshaping, operant, classical, and omission training procedures in rats. J Exp Anal Behav;28(1):59-69, 1977.
5. Aubert Y, Allers KA, Sommer B, de Kloet ER, Abbott DH, Datson NA. Brain regionspecific transcriptomic markers of serotonin-1A receptor agonist action mediating sexual rejection and aggression in female marmoset monkeys. J Sex Med. 2013 Jun;10(6):1461-75.
6. Baas JM and Heitland I. The impact of cue learning, trait anxiety and genetic variation in the serotonin 1A receptor on contextual fear. Int J Psychophysiol. 2014i: S0167-8760(14)01641-9.
7. 1A receptor agonist tandospirone improves executive function in common marmosets. Behav Brain Res. 2015;287:120-126
8. 7 receptor: role in novel object discrimination and relation to novelty-seeking behavior. Neurosci 149(1):192-202, 2007.
9. Barlow RL, Alsiö J, Jupp B, Rabinovich R, Shrestha S, Roberts AC, Robbins TW, Dalley JW. Markers of serotonergic function in the orbitofrontal cortex and dorsal raphé nucleus predict individual variation in spatial-discrimination serial reversal learning. Neuropsychopharmacology. 2015 Jan 8. doi: 10.1038/npp.2014.335. [Epub ahead of print]
10. 2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics. Neuropsychopharmacology. 2015 Jan 7. doi: 10.1038/npp.2015.5
11. Beaudet G, Bouet V, Jozet-Alves C, Schumann-Bard P, Dauphin F, Paizanis E, Boulouard M, Freret T. Spatial memory deficit across aging: current insights of the role of 5-HT7 receptors. Front Behav Neurosci. 2015;8:448.
12. Blenau W and Baumann A (eds). Serotonin Receptor Technologies, Neuromethods, vol. 95, DOI 10.1007/978-1-4939-2187-4_7, © Springer Science+Business Media New York, 2015.
13. Berry JA, Cervantes-Sandoval I, Nicholas EP, Davis RL Dopamine is required for learning and forgetting in Drosophila. Neuron 74:530-542, 2012.
14. Brigman JL, Mathur P, Harvey-White J, Izquierdo A, Saksida LM, Bussey TJ, Fox S, Deneris E, Murphy DL, Holmes A. Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice. Cereb Cortex. 2010 Aug;20(8):1955-63.
15. 4 receptors, a place in the sun: act two. Curr Opin Pharmacol. 2011 Feb;11(1):87-93.
16. 1A receptor in relation to human cognition. Behav Brain Res. 2008;195(1):103-11.
17. 1A receptor binding in humans. Int J Neuropsychopharmacol. 2009;12(6):783-92.
18. Brown PL, Jenkins HM. Auto-shaping of the pigeon's key-peck. J Exp Anal Behav;11(1):1-8, 1968.
19. 1B receptor knockout mouse: selective facilitation/impairment depending on the cognitive demand. Learn Mem. 2003a;10(6):466-77
20. 1B receptor gene deletion on the age-related decline in spatial learning abilities in mice. Behav Brain Res. 2003b;142(1-2):135
21. Bussey TJ, Everitt BJ, Robbins TW. Dissociable effects of cingulate and medial frontal cortex lesions on stimulus-reward learning using a novel Pavlovian autoshaping procedure for the rat: implications for the neurobiology of emotion. Behav Neurosci;111(5):908-19, 1997.
22. Bussey TJ, Barch DM, Baxter MG. Testing long-term memory in animal models of schizophrenia: suggestions from CNTRICS. Neurosci Biobehav Rev;37(9 Pt B):2141-8, 2013.
23. Carmona M, Muraib K, Wanga L, Roberts A and Pasquale E. Glial ephrin-A3 regulates hippocampal dendritic spine morphology and glutamate transport. Proc Natl Acad Sci USA 106:12524-12529, 2009.
24. Callaghan BL, Li S, Richardson R. The elusive engram: what can infantile amnesia tell us about memory? Trends Neurosci 37:47-53, 2014.
25. Cavallaro S. Genomic analysis of serotonin receptors in learning and memory. Behav Brain Res. 2008;195(1):2-6.
26. Chen S, Cai D, Pearce K, Sun PY, Roberts AC, Glanzman DL. Reinstatement of longterm memory following erasure of its behavioral and synaptic expression in Aplysia. Elife. 2014 Nov 17;3. doi: 10.7554/eLife.03896
27. Chen KH, Reese EA, Kim HW, Rapoport SI, Rao JS. Disturbed neurotransmitter transporter expression in Alzheimer's disease brain. J Alzheimers Dis;26(4):755-66, 2011.
28. 7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome. Biol Psychiatry. 2012 Dec 1;72(11):924-33.
29. 3 receptors. Pharmacol Toxicol;71(6):401-15, 1992.
30. Cook R. G., Geller A. I., Zhang G. R., Gowda R. Touch screen-enhanced visual learning in rats. Behav. Res. Meth. Instrum. 36, 101-106, 2004.
31. Davis R. Rac in the act of forgetting. Cell;140:456-458, 2010.
32. Dayer AG, Jacobshagen M, Chaumont-Dubel S, Marin P. 5-HT6 Receptor: A New Player Controlling the Development of Neural Circuits. ACS Chem Neurosci. 2015 Jan 28. [Epub ahead of print] PMID: 25590789.
33. De Filippis B, Chiodi V, Adriani W, Lacivita E, Mallozzi C, Leopoldo M, Domenici MR, Fuso A, Laviola G. Long-1 lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome. Frontiers Behav Neurosci 2015 (in press). doi: 10.3389/fnbeh.2015.00086.
34. 6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia. Curr Pharm Des. 2015 Jun 5. [Epub ahead of print].
35. Delotterie DF, Mathis C, Cassel JC, Rosenbrock H, Dorner-Ciossek C, Marti A. Touchscreen tasks in mice to demonstrate differences between hippocampal and striatal functions. Neurobiol Learn Mem. 2015 Apr;120:16-27.
36. Drago A, Alboni S, Brunello N, De Ronchi D, Serretti A. HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory. Eur J Clin Pharmacol. 2010 Jan;66(1):5-27. Erratum in: Eur J Clin Pharmacol. 2010 Jan;66(1):105.
37. Duewer D, Currie L, Reeder D, Leigh S, Liu H, Mudd L. Interlaboratory comparison of autoradiographic DNA profiling measurements. 2. Measurement uncertainty and its propagation. Anal Chem 67:1220-1231, 1995.
38. 7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors. Neuropharmacology. 2012;63(6):1150-60.
39. Escubedo E, Camarasa J, Chipana C, García-Ratés S, Pubill D. Involvement of nicotinic receptors in methamphetamine-and MDMA-induced neurotoxicity: pharmacological implications. Int Rev Neurobiol; 88:121-66, 2009.
40. Eshkoor, S.A., Hamid, T.A., Mun, C.Y., Ng, C.K. Document mild cognitive impairment and its management in older people. Clinical Interventions in Aging 2015; 10: 687-693.
41. Euston DR, Gruber AJ, McNaughton BL. The role of medial prefrontal cortex in memory and decision making. Neuron;76(6):1057-70, 2012.
42. Fakhfouri G, Mousavizadeh K, Mehr SE, Dehpour AR, Zirak MR, Ghia JE, Rahimian R. From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT3 receptor Antagonists. Mol Neurobiol. 2014 Nov 7. [Epub ahead of print].
43. 7 receptor: effect on object recognition performances in mice. Psychopharmacology 231:393-400, 2014.
44. Fioravanti M and Di Cesare F. Forgetting curves in long-term memory: evidence for a multistage model of retention. Brain Cognition;18:116-124,1992.
45. 2A Receptor System. Neuropsychopharmacology. 2015 Mar 18. doi: 10.1038/npp.2015.46. [Epub ahead of print]. PMID: 25666313
46. Fitzpatrick CJ, Gopalakrishnan S, Cogan ES, Yager LM, Meyer PJ, Lovic V, Saunders BT, Parker CC, Gonzales NM, Aryee E, Flagel SB, Palmer AA, Robinson TE, Morrow JD. Variation in the form of Pavlovian conditioned approach behavior among outbred male Sprague-Dawley rats from different vendors and colonies: sign-tracking vs. goaltracking. PLoS One. 2013; 8(10):e75042.
47. 6 receptor effects on striatal circuit function. Neuroscience, doi:10.1016/j.neuroscience.2015.04.046
48. Gallistel CR, Balci F, Freestone D, Kheifets A, King A. Automated, quantitative cognitive/behavioral screening of mice: for genetics, pharmacology, animal cognition and undergraduate instruction. J. Vis. Exp. (84), e51047, doi:10.3791/51047 (2014).
49. 6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease. Neuropsychopharmacology. 2004;29(2):410-6.
50. Garcia-Garcia AL, Elizalde N, Matrov D, Harro J, Wojcik SM, Venzala E, Ramírez MJ, Del Rio J, Tordera RM. Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1.Biol Psychiatry;66(3):275-82, 2009.
51. 7 antagonist SB-269970 in the modulation of working and reference memory in the rat. Behav Brain Res. 2008;195(1):164-70.
52. 7 receptors and cognition. Rev Neurosci. 2014;25(3):311-23.
53. 5A receptors in the consolidation of memory. Behav Brain Res 252:246-251, 2013.
54. 1A receptor binding is related to objectlocation memory in humans. Brain Struct Funct. 2015;220(1):559-70.
55. 1A receptor agonists F15599 and F13714 in a novel object pattern separation task. Br J Pharmacol. 2015 Jan 9. doi: 10.1111/bph.13071.
56. 2A receptor polymorphism (HIS452TYR) and memory performances in alzheimer's disease. Int J Neurosci. 2015 May 22:1-16.
57. 7 receptor-mediated signaling. Front Behav Neurosci. 2014;8:306.
58. Gyurko MD, Stetak A, Soti C, Csermely P. Multitarget network strategies to influence memory and forgetting: the ras/mapk pathway as a novel option. Mini Rev Med Chem. 2015;15(8):696-704
59. Ha CM, Park D, Kim Y, Na M, Panda S, Won S, Kim H, Ryu H, Park ZY, Rasenick MM, Chang S. SNX14 is a bifunctional negative regulator for neuronal 5-HT6 receptor signaling. J Cell Sci. 2015 Mar 20. pii: jcs.169581. [Epub ahead of print] PMID: 25795301.
60. 4 receptor levels in hippocampus correlates inversely with memory test performance in humans. Hum Brain Mapp. 2013 Nov;34(11):3066-74.
61. 6 receptor signaling. J Cell Sci doi: 10.1242/ jcs.169581.
62. 7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone. Behav Brain Res. 2013;244:66-9.
63. Hashimoto K. Tropisetron and its targets in Alzheimer's disease. Expert Opin Ther Targets. 2015;19(1):1-5.
64. Hardt O, Nader K, Nadel L. Decay happens: the role of active forgetting in memory. Trends Cogn Sci;17:111-120, 2013.
65. 18F] altanserin. Neuroimage. 2011;58(3):905-11.
66. Heo S, Jung G, Beuk T, Höger H, Lubec G. Hippocampal glutamate transporter 1 (GLT-1) complex levels are paralleling memory training in the Multiple T-maze in C57BL/6J mice. Brain Struct Funct. 2012;217(2):363-78.
67. Holland PC, Asem JS, Galvin CP, Keeney CH, Hsu M, Miller A, Zhou V. Blocking in autoshaped lever-pressing procedures with rats. Learn Behav;42(1):1-21, 2014.
68. Horner AE, Heath CJ, Hvoslef-Eide M, Kent BA, Kim CH, Nilsson SR, Alsiö J, Oomen CA, Holmes A, Saksida LM, Bussey TJ. The touchscreen operant platform for testing learning and memory in rats and mice. Nat Protoc. 2013;8(10):1961-84.
69. 6 receptor inverse agonists. Chem Biol Drug Design 83 (6): 666-669, 2014
70. Hu J and Quick M. Substrate-mediated regulation of γ-aminobutyric acid transporter 1 in rat brain. Neuropharmacology 54:309-318, 2008.
71. 6 receptor mRNA expression during memory consolidation and amnesia. Neurobiol Learn Mem. 2010;93(1):99-110
72. Hupbach A. When forgetting preserves memory. Front Psychol;4:32, 2013.
73. Kandel ER. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294;1030-1038, 2001.
74. Kaku M, Yamada K, Ichitani Y. Can rats control previously acquired spatial information? Evidence of "directed forgetting" phenomenon in delay-interposed radial maze behavior. Behav Brain Res;248:1-6, 2013.
75. Karimi B, Hafidzi MN, Panandam JM, Fuzina NH. Comparison of effect of sex hormone manipulation during neonatal period, on mRNA expression of Slc9a4, Nr3c2, Htr5b and Mas1 in hippocampus and frontal cortex of male and female rats. J Biol Regul Homeost Agents. 2013;27(3):869-74.
76. Kozuska JL, Paulsen IM, Belfield WJ, Martin IL, Cole DJ, Holt A, Dunn SM. Impact of intracellular domain flexibility upon properties of activated human 5-HT3 receptors. Br J Pharmacol. 2014;171(7):1617-28
77. Kindlundh-Högberg AM, Blomqvist A, Malki R, Schiöth HB. Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats. BMC Neurosci;17:9:3, 2008.
78. Kitamura S, Yasuno F, Inoue M, Kosaka J, Kiuchi K, Matsuoka K, Kishimoto T, Suhara T. Increased binding of 5-HT1A receptors in a dissociative amnesic patient after the recovery process. Psychiatry Res. 2014;224(1):67-71.
79. 3 receptor is essential for exercise-induced hippocampal neurogenesis and antidepressant effects. Molecular Psychiatry, doi:10.1038/mp.153, 2014.
80. Köppen JR, Winter SS, Stuebing SL, Cheatwood JL, Wallace DG. Infusion of GAT1-saporin into the medial septum/vertical limb of the diagonal band disrupts selfmovement cue processing and spares mnemonic function. Brain Struct Funct. 2013 Sep;218(5):1099-114.
81. Krynetskiy E, Krynetskaia N, Rihawi D, Wieczerzak K, Ciummo V, Walker E. Establishing a model for assessing DNA damage in murine brain cells as a molecular marker of chemotherapy-associated cognitive impairment. Life Sci. 2013 Oct 17; 93(17):605-10.
82. Lau T, Proissl V, Ziegler J, Schloss P. Visualization of neurotransmitter uptake and release in serotonergic neurons. J Neurosci Methods. 2015 Feb 15;241:10-7
83. Lecoutey C, Hedou D, Freret T, Giannoni P, Gaven F, Since M, Bouet V, Ballandonne C, Corvaisier S, Malzert Fréon A, Mignani S, Cresteil T, Boulouard M, Claeysen S, Rochais C, Dallemagne P. Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment. Proc Natl Acad Sci U S A; 111(36):E3825-30, 2014.
84. Leger M, Paizanis E, Dzahini K, Quiedeville A, Bouet V, Cassel JC, Freret T, Schumann-Bard P, Boulouard M. Environmental Enrichment Duration Differentially Affects Behavior and Neuroplasticity in Adult Mice. Cereb Cortex. 2014 Jun 5. pii: bhu119. [Epub ahead of print] PMID: 2490407.
85. Leiser SC, Li Y, Pehrson AL, Dale E, Smagin G, Sanchez C. Serotonergic regulation of prefrontal cortical circuitries involved in cognitive processing: A review of individual 5-HT receptor mechanisms and concerted effects of 5-HT receptors exemplified by the multimodal antidepressant vortioxetine.ACS Chem Neurosci. 2015 Mar 6. [Epub ahead of print] PMID: 25746856.
86. Lim CS, Hoang ET, Viar KE, Stornetta RL, Scott MM, Zhu JJ. Pharmacological rescue of Ras signaling, GluA1-dependent synaptic plasticity, and learning deficits in a fragile X model. Genes Dev. 2014;28(3):273-89.
87. Lesaint F, Sigaud O, Flagel SB, Robinson TE, Khamassi M. Modelling individual differences in the form of Pavlovian conditioned approach responses: a dual learning systems approach with factored representations. PLoS Comput Biol;10(2):e1003466, 2014.
88. Li LB, Zhang L, Sun YN, Han LN, Wu ZH, Zhang QJ, Liu J. Activation of serotonin2A receptors in the medial septum-diagonal band of Broca complex enhanced working memory in the hemiparkinsonian rats. Neuropharmacology. 2015a;91:23-33.
89. Li HJ, Peng RY, Wang CZ, Qiao SM, Yong Z, Gao YB, Xu XP, Wang SX, Dong J, Zuo HY, Li Z, Zhou HM, Wang LF, Hu XJ. Alterations of cognitive function and 5-HT system in rats after long term microwave exposure. Physiol Behav. 2015b;140:236-46 Li S, Richardson R. Traces of memory: reacquisition of fear following forgetting is NMDAr-independent. Learn Mem; 20:174-182, 2013.
90. Li Y, Abdourahman A, Tamm JA, Pehrson AL, Sánchez C, Gulinello M. Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice. Pharmacol Biochem Behav. 2015c Jun 1;135:70-82. doi: 10.1016/j.pbb.2015.05.013
91. Lindner MD, Hodges DB Jr, Hogan JB, Orie AF, Corsa JA, Barten DM, Polson C, Robertson BJ, Guss VL, Gillman KW, Starrett JE Jr, Gribkoff VK. An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning. J Pharmacol Exp Ther;307(2):682-91, 2003.
92. Line SJ, Barkus C, Rawlings N, Jennings K, McHugh S, Sharp T, Bannerman DM. Reduced sensitivity to both positive and negative reinforcement in mice over-expressing the 5-hydroxytryptamine transporter. Eur J Neurosci. 2014;40(12):3735-45
93. Ludowiq E, Möller J, Bien C, Münte T, Elger C, Rosburg T. Active suppression in the mediotemporal lobe during directed forgetting. Neurobiol Learning Memory 93:352-361, 2010.
94. Lynch, M.A. (2004). Long term potentiation. Physiol Rev;84:87-136.
95. Madsen K, Neumann WJ, Holst K, Marner L, Haahr MT, Lehel S, Knudsen GM, Hasselbalch SG. Cerebral serotonin 4 receptors and amyloid-β in early Alzheimer's disease. J Alzheimers Dis. 2011;26(3):457-66.
96. Mansuy IM. Forgetting: theories and potential mechanisms. Med Sci 21:83-88, 2005.
97. 6 receptor functions in behavioral symptoms of Alzheimer's disease. J Alzheimer's Dis;14:43-50, 2008.
98. 4 receptors using an olfactory associative discrimination task. Brain Res. 2011;1405:49-56
99. Marcus E. Credibility and reproducibility. Cel;159(5):965-6, 2014.
100. Markou A, Salamone JD, Bussey TJ, Mar AC, Brunner D, Gilmour G, Balsam P. Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia. Neurosci Biobehav Rev;37:2149-2165, 2013.
101. McConathy J and Sheline YI. Imaging Biomarkers Associated With Cognitive Decline: A Review. Biol Psychiatry. 2015;77(8):685-692.
102. McGaugh JL. Making lasting memories: remembering the significant. Proc Natl Acad Sci USA;110:10402-10407, 2013.
103. McCorvy JD, Roth BL. Structure and function of serotonin G protein-coupled receptors. Pharmacol Ther. 2015 Jan 17. pii: S0163-7258(15)00029-7. doi: 10.1016/j.pharmthera.2015.01.009. [Epub ahead of print]
104. McHugh SB, Barkus C, Lima J, Glover LR, Sharp T, Bannerman DM. SERT and uncertainty: serotonin transporter expression influences information processing biases for ambiguous aversive cues in mice. Genes Brain Behav. 2015 Mar 30. doi: 10.1111/gbb.12215.
105. Marin P, Becamel C, Dumuis A, Bockaert. 5-HT receptor-associated protein networks: new targets for drug discovery in psychiatric disorders? J. Curr Drug Targets. 2012;13(1):28-52.
106. Ménard C, Gaudreau P and Quirion R. (2015). Signaling pathways relevant to cognitionenhancing drug targets. In: KM Kantak and JG Wettstein (eds.), Cognitive Enhancement, Handbook of Experimental Pharmacology 228, DOI 10.1007/978-3-319-16522-6_3.
107. Ménard C and Quirion R (2012) Successful Cognitive Aging in Rats: A Role for mGluR5 Glutamate Receptors, Homer 1 Proteins and Downstream Signaling. Pathways. PLoS ONE 7(1): e28666. doi:10.1371/journal.pone.0028666
108. Meneses A. 5-HT systems: emergent targets for memory formation and memory alterations. Rev Neurosci;24:629-664, 2013.
109. Meneses A. Neurotransmitters and Memory: Cholinergic, Glutamatergic, GABAergic, Dopaminergic, Serotonergic, Signaling, and Memory. In Identification of Neural Markers Accompanying Memory. Meneses A (ed), Elsevier, San Diego, USA, pp: 5-45, 2014.
110. 1B receptor inverse agonism affect learning consolidation? Neurosci Biobehav Rev. 2001 Mar;25(2):193-201.
111. Meneses A, Liy-Salmeron G. Serotonin and emotion, learning and memory. Rev Neurosci. 2012;23(5-6):543-53.
112. Meneses A, Perez-Garcia G, Ponce-Lopez T, Tellez R, Gallegos-Cari A, Castillo C. Spontaneously hypertensive rat (SHR) as an animal model for ADHD: a short overview. Rev Neurosci. 2011a;22(3):365-71
113. Meneses A, Perez-Garcia G, Ponce-Lopez T, Tellez R, Castillo C. Serotonin transporter and memory. Neuropharmacology;61:355-363, 2011b.
114. 6 receptor memory and amnesia: behavioral pharmacology--learning and memory processes. Int Rev Neurobiol. 2011c;96:27-47.
115. Meneses A and Tellez R. Autoshaping Memory Formation and Retention Loss: Are Serotonin and Other Neurotransmitter Transporters Involved? In: W Blenau and A Baumann (eds). Serotonin Receptor Technologies, Neuromethods, vol. 95, DOI 10.1007/978-1-4939-2187-4_7, © Springer Science+Business Media New York, 2015.
116. Mereu M, Bonci A, Newman AH, Tanda G. The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology (Berl);229(3):415-34, 2013.
117. Meyer-Lindenberg A, Murphy D, Rolls E, Saletu B, Spedding M, Sweeney J, Whittington M, Young LJ. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov; 1(2):141-68, 2012.
118. Millan MJ, Agid Y, Brüne M, Bullmore ET, Carter CS, Clayton NS, Connor R, Davis S, Deakin B, DeRubeis RJ, Dubois B, Geyer MA, Goodwin GM, Gorwood P, Jay TM, Joëls M, Mansuy IM, Molinuevo JL, Blennow K, Dubois B, Engelborghs S, Lewczuk P, Perret-Liaudet A, Teunissen CE, Parnetti L. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimers Dement. 2014;10(6):808-817.
119. Mo C, Hannan AJ, Renoir T. Environmental factors as modulators of neurodegeneration: Insights from gene-environment interactions in Huntington's disease. Neurosci Biobehav Rev. 2015 Mar 10;52:178-192.
120. Monje, F.J., Divisch, I., Demit, M., Lubec, G., and Pollak, D.D. (2013). Flotillin-1 is an evolutionary-conserved memory-related protein up-regulated in implicit and explicit learning paradigms. Ann. Med. 45, 301-307.
121. Mora F. Successful brain aging: plasticity, environmental enrichment, and lifestyle. Dialogues Clin Neurosci. 2013 Mar;15(1):45-52.
122. 3A receptors. Br J Pharmacol. 2015 May 18. doi: 10.1111/bph.
123. Muenchhoff J, Poljak A, Song F, et al. Plasma Protein Profiling of Mild Cognitive Impairment and Alzheimer's Disease Across Two Independent Cohorts J Alzheimer's disease 43 (4): 1355-1373, 2015.
124. Müller CP, Homberg JR. The role of serotonin in drug use and addiction. Behav Brain Res. 2015 Jan 15;277:146-92.
125. Myer JS, and Hull JH. Autoshaping and instrumental learning in the rat. J Comp Physiol Psychol 86(4):724-729, 1974.
126. Myhrer T. Neurotransmitter systems involved in learning and memory in the rat: a metaanalysis based on studies of four behavioral tasks. Brain Res Rev;41:268-287, 2003.
127. Myer JS, and Hull JH. Autoshaping and instrumental learning in the rat. J Comp Physiol Psychol 86(4): 724-729, 1974.
128. 2A/2B/2C receptors in harmaline-induced amnesia. Pharmacol Biochem Behav. 2014;125:70-7.
129. Nasehi M, Tabatabaie M, Khakpai F, Zarrindast M. The effects of CA1 5HT4 receptors in MK801-induced amnesia and hyperlocomotion. Neurosci Lett. 2014b;587C:73-78.
130. Nikiforuk A. Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date.CNS Drugs. 2015 Feb 27. [Epub ahead of print]. PMID: 25721336.
131. 7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenialike deficits in rats. PLoS One. 2013 Jun 11;8(6):e66695.
132. Oscos A, Martinez JL Jr, McGaugh JL. Effects of post-training d-amphetamine on acquisition of an appetitive autoshaped lever press response in rats. Psychopharmacology (Berl);95(1):132-4, 1988.
133. Pang KC, Jiao X, Sinha S, Beck KD, Servatius RJ. Damage of GABAergic neurons in the medial septum impairs spatial working memory and extinction of active avoidance: effects on proactive interference. Hippocampus. 2011;21(8):835-46
134. Papenberg G, Bäckman L, Nagel IE, Nietfeld W, Schröder J, Bertram L, Heekeren HR, Lindenberger U, Li SC. Dopaminergic gene polymorphisms affect long-term forgetting in old age: further support for the magnification hypothesis. J Cogn Neurosci; 25:571-579, 2013.
135. Patton W. Biologist's perspective on analytical imaging systems as applied to protein gel electrophoresis. J Chromatography A;698:55-87, 1995.
136. Parrott AC. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users. Neurosci Biobehav Rev; 37(8):1466-84, 2013.
137. Peele DB & Vincent A. Strategies for assessing learning and memory, 1978-1987: a comparison of behavioral toxicology, psychopharmacology, and neurobiology. Neurosci Biobehav Rev. 13(4),317-22, 1989.
138. 7 receptors. Behav Brain Res;202:102-113, 2009.
139. 7 receptor agonists and antagonists on cAMP accumulation during memory formation and amnesia. Behav Brain Res;195:139-146, 2008.
140. 7 receptors during memory consolidation. Behav Brain Res;169:83-92, 2006.
141. 7 receptor agonist AS 19 in an autoshaping learning task. Behav Brain Res. 2005;163(1):136-40.
142. 4 receptors and forebrain cholinergic system: receptor expression in identified cell populations. Brain Struct Funct. 2014 Sep 3. [Epub ahead of print] PMID: 25183542.
143. 1A receptor ligands. Eur J Neuropsychopharmacol 2015, http://dx.doi.org/10.1016/j.euroneuro.2015.04.017
144. Puig MV and Gulledge AT. Serotonin and Prefrontal Cortex Function: Neurons, Networks, and Circuits. Mol Neurobiol.; 44(3): 449-464, 2011.
145. Ramirez MJ, Lai MK, Tordera RM, Francis PT. Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status. Drugs. 2014 May;74(7):729-36.
146. Pithers RT. The roles of event contingencies and reinforcement in human autoshaping and omission responding. Learning Motivation 16 (2): 210-237, 1985.
147. Pitychoutis PM, Belmer A, Moutkine I, Adrien J, Maroteaux L. Mice lacking the serotonin Htr2B receptor gene present an antipsychotic-sensitive schizophrenic-like phenotype. Neuropsychopharmacology. 2015 May 4. doi: 10.1038/npp.2015.126.
148. Ramirez MJ, Lai MK, Tordera RM, Francis PT. Drugs. 2014 May;74(7):729-36.
149. Reichel CM, Ramsey LA, Schwendt M, McGinty JF, See RE. Methamphetamineinduced changes in the object recognition memory circuit. Neuropharmacology;62:1119-1126, 2012.
150. 4 receptors activation is mediated by a potentiation of learning-induced spine growth in the mouse hippocampus. Neuropsychopharmacol. 2008;33(10):2427-34
151. Rodriguez JS, Boctor SY, Phelix CF, Martinez JL Jr. Differences in performance between Sprague-Dawley and Fischer 344 rats in positive reinforcement tasks. Pharmacol Biochem Behav;89(1):17-22, 2008.
152. Rodríguez JJ, Noristani HN, Verkhratsky A. The serotonergic system in ageing and Alzheimer's disease. Prog Neurobiol;99(1):15-41, 2012.
153. 7 receptors in cultured hippocampal neurons. J Neurosci Res. 2014 Aug;92(8):1000-9.
154. Ruocco LA, Treno C, Gironi Carnevale UA, Arra C, Boatto G, Nieddu M, Pagano C, Illiano P, Barbato F, Tino A, Carboni E, Laviola G, Lacivita E, Leopoldo M, Adriani W, Sadile AG. Prepuberal stimulation of 5-HT7-R by LP-211 in a rat model of hyper-activity and attention-deficit: permanent effects on attention, brain amino acids and synaptic markers in the fronto-striatal interface. PLoS One. 2014;9(4):e83003. doi: 10.1371.
155. Salat K, Podkowa A, Mogilski S, Zareba P, Kulig K, Salat R, Malikowska N and Filipek B. The effect of GABA transporter 1 (GAT1) inhibitor, tiagabine, on scopolamineinduced memory impairments in mice. Pharmacological Reports, 2015. doi.org/10.1016/j.pharep.2015.04.018.
156. Saroja SR, Kim EJ, Shanmugasundaram B, Höger H, Lubec G. Hippocampal monoamine receptor complex levels linked to spatial memory decline in the aging C57BL/6J. Behav Brain Res;264:1-8, 2014.
157. Saulin A1, Savli M, Lanzenberger R. Serotonin and molecular neuroimaging in humans using PET. Amino Acids. 2012;42(6):2039-57.
158. 1A-containing receptor complexes. Behav Brain Res. 2014;278C:44-54.
159. Scarr E, Millan MJ, Bahn S, Bertolino A, Turck CW, Kapur S, Möller HJ, Dean B. Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank. Int J Neuropsychopharmacol. 2015 Apr 21. pii: pyv042. doi: 10.1093/ijnp/pyv042
160. Segu L, Lecomte MJ, Wolff M, Santamaria J, Hen R, Dumuis A, Berrard S, Bockaert J, Buhot MC, Compan V. Hyperfunction of muscarinic receptor maintains long-term memory in 5-HT4 receptor knock-out mice. PLoS One. 2010 Mar 4;5(3):e9529.
161. Seo J, Tsai LH. Neuronal differentiation: 5-HT6R can do it alone. Nat Chem Biol. 2014;10(7):488-9.
162. Seyedabadi M, Fakhfouri G, Ramezani V, Mehr SE, Rahimian R. The role of serotonin in memory: interactions with neurotransmitters and downstream signaling. Exp Brain Res; 232:723-738, 2014.
163. Schmitt U and Hiemke C. Tiagabine, a gamma-amino-butyric acid transporter inhibitor impairs spatial learning of rats in the Morris water-maze. Behav Brain Res;133(2):391-4, 2002.
164. Sheline YI, West T, Yarasheski K, Swarm R, Jasielec MS, Fisher JR, Ficker WD, Yan P, Xiong C, Frederiksen C, Grzelak MV, Chott R, Bateman RJ, Morris JC, Mintun MA, Lee JM, Cirrito JR. An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice. Sci Transl Med; 6(236):236re4, 2014a.
165. Sheline YI, West T, Yarasheski K, Jasielec MS, Hettinger JC, Tripoli DL, Xiong C, Frederiksen C, Grzelak MV, Bateman RJ, Morris JC, Lee JM, Cirrito JR. Reply to comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice". Sci Transl Med. 2014b Dec 24;6(268):268lr4. doi: 10.1126/scitranslmed.3010609.
166. Shi J, Cai Y, Liu G, Gong N, Liu Z, Xu T, Wang Z, Fei J. Enhanced learning and memory in GAT1 heterozygous mice. Acta Biochim Biophys Sin (Shanghai);44(4):359-6, 2012.
167. Shimizu S, Mizuguchi Y, Ohno Y. Improving the treatment of schizophrenia: role of 5-HT receptors in modulating cognitive and extrapyramidal motor functions. CNS Neurol Disord Drug Targets. 2013 Sep;12(6):861-9.
168. Sidiropoulou K, Chao S, Lu W, Wolf M. Amphetamine administration does not alter protein levels of the GLT-1 and EAAC1 glutamate transporter subtypes in rat midbrain, nucleus accumbens, striatum, or prefrontal cortex. Mol Brain Res;90:187-192, 2001.
169. Silverman JL, Gastrell PT, Karras MN. Solomon J and Crawley JN. Cognitive Abilities on Transitive Inference Using a Novel Touchscreen Technology for Mice Cerebral Cortex May 2015;25:1133-1142.
170. Solodkin A, and van Hoesen G. Neuropathology and functional anatomy of Alzheimer's disease. In: Brioni J, Decker M, editors. Pharmacological treatment of Alzheimer's disease. New York: Wiley-Liss, pp151-177, 1997.
171. Söderqvist S, Bergman Nutley S, Peyrard-Janvid M, Matsson H, Humphreys K, Kere J, Klingberg T. Dopamine, working memory, and training induced plasticity: implications for developmental research. Dev Psychol;48(3):836-43, 2012.
172. Strac DS, Muck-Seler D, Pivac N. Neurotransmitter measures in the cerebrospinal fluid of patients with Alzheimer's disease: a review. Psychiatr Danub. 2015;27(1):14-24.
173. Sun MK, Nelson TJ, Alkon DL. Towards universal therapeutics for memory disorders. Trends Pharmacol Sci. 2015 May 7. pii: S0165-6147(15)00076-0. doi: 10.1016/j.tips.2015.04.004
174. Subramaniyan S, Heo S, Patil S, Li L, Hoger H, Pollak A, Lubec G A hippocampal nicotinic acetylcholine alpha 7-containing receptor complex is linked to memory retrieval in the multiple-T-maze in C57BL/6j mice. Behav Brain Res. 2014;270:137-45.
175. Subramaniyan S, Hajali V, Scherf T, Sase SJ, Sialana FJ, Gröger M, Bennett KL, Pollak A, Li L, Korz V, Lubec G. Hippocampal receptor complexes paralleling LTP reinforcement in the spatial memory holeboard test in the rat. Behav Brain Res. 2015;283C:162-174
176. Sumiyoshi T, Bubenikova-Valesova V, Horacek J, Bert B. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics. Adv Ther. 2008 Oct;25(10):1037-56
177. Suzuki H1, Lucas LR. Neurochemical correlates of accumbal dopamine D2 and amygdaloid 5-HT 1B receptor densities on observational learning of aggression. Cogn Affect Behav Neurosci. 2015 Feb 4. [Epub ahead of print].
178. Stroth, N., Niso, M., Colabufo, N.A., Perrone, R., Svenningsson, P., Lacivita, E., Leopoldo, M., Arylpiperazine Agonists of the Serotonin 5-HT1A Receptor Preferentially Activate cAMP Signaling versus. Recruitment of β-Arrestin-2, Bioorganic & Medicinal Chemistry (2015), doi: http://dx.doi.org/10.1016/j.bmc. 2015.05.042
179. 7 receptor blockade reverses behavioral abnormalities in PACAP-deficient mice and receptor activation promotes neurite extension in primary embryonic hippocampal neurons: therapeutic implications for psychiatric disorders. J Mol Neurosci. 2012;48(3):473-81.
180. Talpos JC, Aerts N, Fellini L, Steckler T. A touch-screen based paired-associates learning (PAL) task for the rat may provide a translatable pharmacological model of human cognitive impairment. Pharmacol Biochem Behav;122:97-106, 2014.
181. Talpos J, Shoaib M. Executive function. Handb Exp Pharmacol. 2015;228:191-213.
182. Tellez R, Rocha L, Castillo C, Meneses A. Autoradiographic study of serotonin transporter during memory formation. Behav Brain Res;12:12-26, 2010.
183. Tellez R, Gómez-Víquez L, Meneses A. GABA, glutamate, dopamine and serotonin transporters expression on memory formation and amnesia. Neurobiol Learn Mem;97:189-201, 2012a.
184. Tellez R, Gómez-Viquez L, Liy-Salmeron G, Meneses A. GABA, glutamate, dopamine and serotonin transporters expression on forgetting. Neurobiol Learn Mem;98:66-77, 2012b.
185. Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. J Psychopharmacol;20(2):211-25, 2006.
186. 3 receptor pharmacology. Trends Pharmacol Sci. 2013;34(2):100-9.
187. Thur KE, Nelson AJ, Cassaday HJ. Ro 04-6790-induced cognitive enhancement: no effect in trace conditioning and novel object recognition procedures in adult male Wistar rats. Pharmacol Biochem Behav. 2014 Dec;127:42-8. doi: 10.1016/j.pbb.2014.10.006. Epub 2014 Oct 24.
188. 2a binding in rat brain. Brain Res;975(1-2):167-78, 2003.
189. Tomie A, Lincks M, Nadarajah SD, Pohorecky LA, Yu L. Pairings of lever and food induce Pavlovian conditioned approach of sign-tracking and goal-tracking in C57BL/6 mice Behav Brain Res;226(2):571-578, 2012.
190. Vanover KE, Harvey SC, Son T, Bradley SR, Kold H, Makhay M, Veinbergs I, Spalding TA, Weiner DM, Andersson CM, Tolf BR, Brann MR, Hacksell U, Davis RE. Pharmacological characterization of AC-90179 [2-(4-methoxyphenyl)-N-(4-methylbenzyl)-N-(1-methyl-piperidin-4-yl)-acetamide hydrochloride]: a selective serotonin 2A receptor inverse agonist. J Pharmacol Exp Ther;310(3):943-51, 2004.
191. 1B receptor imaging and cognition: A positron emission tomography study in control subjects and Parkinson's disease patients. Synapse. 2015 Apr 24. doi: 10.1002/syn.21823.
192. Vardy E, Kenakin T. The tail wags the dog: possible mechanism for reverse allosteric control of ligand-activated channels. Br J Pharmacol. 2014 Apr;171(7):1614-6.
193. Vimala PV, Bhutada PS, Patel FR. Therapeutic potential of agomelatine in epilepsy and epileptic complications. Med Hypotheses. 2014;82(1):105-10.
194. Wagner A and Davachi L Cognitive neuroscience: forgetting of things past. Curr Biol;11: R964-967, 2001.
195. Wallace A, Pehrson AL, Sánchez C, Morilak DA. Vortioxetine restores reversal learning impaired by 5-HT depletion or chronic intermittent cold stress in rats. Int J Neuropsychopharmacol. 2014 Oct;17(10):1695-706.
196. Walker EA, Foley JJ, Clark-Vetri R, Raffa RB. Effects of repeated administration of chemotherapeutic agent tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice. Psychopharmacology (Berl);217(4):539-48, 2011.
197. 2C ligands in a mouse autoshaping-operant procedure. Behav Pharmacol. 2010;21(2):83-9.
198. Wasserman EA. Response evocation in autoshaping: Contribution of cognitive and comparative_evolutionary analysis to an understanding of directed action. In CM Locurto, HS Terrace J Gibbon (eds) Autoshaping and conditioning theory. Academic Press, New York, 1981.
199. 7 receptor antagonist SB-269970 in animal models of psychosis and cognition. Behav Brain Res. 2012 Mar 1;228(1):211-8.
200. Weber T, Vogt MA, Gartside SE, Berger SM, Lujan R, Lau T, Herrmann E, Sprengel R, Bartsch D, Gass P. Adult AMPA GLUA1 Receptor Subunit Loss in 5-HT Neurons Results in a Specific Anxiety-Phenotype with Evidence for Dysregulation of 5-HT Neuronal Activity. Neuropsychopharmacology. 2015;40(6):1471-1484.
201. Wellman CL, Izquierdo A, Garrett JE, Martin KP, Carroll J, Millstein R, Lesch KP, Murphy DL, Holmes A. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci;27:684-691, 2007.
202. 7 receptors in vortioxetine's modulation of circadian rhythms and episodic memory in rodents. Neuropharmacol 89:382-90, 2015.
203. Wilcove, W. Gregg; Miller, Joseph C. CS-UCS presentations and a lever: Human autoshaping. J Experimental Psycho 103(5): 868-877, 1974.
204. 6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2014;13(11):1092-9.
205. Wixted JT. The psychology and neuroscience of forgetting. Annu Rev Psychol;55:235-69, 2004.
206. Wolf JE, Urbano CM, Ruprecht CM, Leising KJ. Need to train your rat? There is an App for that: a touchscreen behavioral evaluation system. Behav Res Methods;46(1):206-14, 2014.
207. Wolff M, Savova M, Malleret G, Hen R, Segu L, Buhot MC. Serotonin 1B knockout mice exhibit a task-dependent selective learning facilitation. Neurosci Lett. 2003;20;338:1-4.
208. 6 receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms. Br J Pharmacol;167:436-449, 2012.
209. 5A receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia. Eur Neuropsychopharmacol. 2014;24(10):1698-708.
210. 5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats. J Pharmacol Sci. 2015 Mar;127(3):362-9
211. Yang P, Cai G, Cai Y, Fei J, Liu G. Gamma aminobutyric acid transporter subtype 1 gene knockout mice: a new model for attention deficit/hyperactivity disorder. Acta Biochim Biophys Sin (Shanghai);45(7):578-85, 2013.
212. 1A receptors. Pharmacol Biochem Behav. 2014;124:245-9.
213. Zaldivar A, Krichmar JL. Interactions between the neuromodulatory systems and the amygdala: exploratory survey using the Allen Mouse Brain Atlas. Brain Struct Funct. 2013;218(6):1513-30.
214. Zilles K, Bacha-Trams M, Palomero-Gallagher N, Amunts K, Friederici AD. Common molecular basis of the sentence comprehension network revealed by neurotransmitter receptor fingerprints. Cortex. 2015 February; 63: 79-89.